Iceni BioDiscovery Limited Company Profile

06:30 EST 25th November 2017 | BioPortfolio

Iceni BioDiscovery Ltd is a product-focused biotechnology company that is developing commercial cell therapies for unmet medical needs. Iceni will initially target diabetes where recent success in transplantation has created a requirement for more human tissue than is available from organ donors. Diabetes is a major and growing disease that would substantially benefit from a new treatment to restore physiological control of blood glucose levels. Nine percent of the UK National Health Service budget is spent on costs related to diabetes and its complications, islet transplantation is the only treatment for diabetes that can avoid these complications. Iceni’s products are based on insulin-producing cells, grown in the laboratory, that will greatly increase the number of patients that can receive a transplant. Products for treating other chronic diseases are in the pipeline. The Intellectual Property being developed by Iceni also opens opportunities for commercial collaborations and out-licensing.

Iceni obtained seed funding from Avlar and Prelude in April 2001 and completed a £3 million equity investment from three venture capital funds (Avlar, Novartis Venture Fund and Prelude) at the beginning of July 2001. A second round of funding will be completed in early 2003.

News Articles [23 Associated News Articles listed on BioPortfolio]

BigDNA rebrands as Iceni

Iceni Diagnostics [Report Updated: 09082017] Prices from USD $190

VAT on report purchase of $950

How would you spend 192 Million Euros on Biotech and Medical Devices?

During BioTrinity 2014 Olivier Litzka, Partner, Edmond de Rothschild Investment Partners talks to Fintan Walton about BioDiscovery IV and how they will be investing the fund.

New programme aims to put the spotlight on region's growing bio-economy

David Russell, left, chief scientific officer, and Rob Field, chief executive of Iceni Diagnostics at work in their lab. Picture: DENISE BRADLEY.

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Fast Science and Sluggish Policy: The Herculean Task of Regulating Biodiscovery.

New rules for access and benefit sharing (ABS) of genetic resources and associated traditional knowledge have been established by the Nagoya Protocol but have not kept up with rapid scientific and tec...

Coagulating Colubrids: Evolutionary, Pathophysiological and Biodiscovery Implications of Venom Variations between Boomslang (Dispholidus typus) and Twig Snake (Thelotornis mossambicanus).

Venoms can deleteriously affect any physiological system reachable by the bloodstream, including directly interfering with the coagulation cascade. Such coagulopathic toxins may be anticoagulants or p...

Venom Profiling of a Population of the Theraphosid Spider Phlogius crassipes Reveals Continuous Ontogenetic Changes from Juveniles through Adulthood.

Theraphosid spiders (tarantulas) are venomous arthropods found in most tropical and subtropical regions of the world. Tarantula venoms are a complex cocktail of toxins with potential use as pharmacolo...

UV-Resistant Actinobacteria from High-Altitude Andean Lakes: Isolation, Characterization and Antagonistic Activities.

Polyextremophiles are present in a wide variety of extreme environments in which they must overcome various hostile conditions simultaneously such as high UVB radiation, extreme pHs and temperatures, ...

Clinical Trials [0 Results]


Companies [84 Associated Companies listed on BioPortfolio]

Iceni BioDiscovery Limited

Iceni BioDiscovery Ltd is a product-focused biotechnology company that is developing commercial cell therapies for unmet medical needs. Iceni will initially target diabetes where recent success in tr...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

BioDiscovery New Zealand Limited

BDNZ is New Zealand’s leading centre of expertise on Bacillus thuringiensis (Bt) and high throughput screening (HTS) of invertebrate pests. Key activities include isolation and evaluation of B...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...


More Information about "Iceni BioDiscovery Limited" on BioPortfolio

We have published hundreds of Iceni BioDiscovery Limited news stories on BioPortfolio along with dozens of Iceni BioDiscovery Limited Clinical Trials and PubMed Articles about Iceni BioDiscovery Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Iceni BioDiscovery Limited Companies in our database. You can also find out about relevant Iceni BioDiscovery Limited Drugs and Medications on this site too.

Quick Search

Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...

Corporate Database Quicklinks

Searches Linking to this Company Record